Effect of Acute Bleeding on Daily Quality of Life Assessments in Patients with Congenital Hemophilia with Inhibitors and Their Families: Observations from the Dosing Observational Study in Hemophilia
Neufeld, Ellis J., MD, PhD, Recht, Michael, MD, PhD, Sabio, Hernan, MD, Saxena, Kapil, MD, Solem, Caitlyn T., PhD, Pickard, A. Simon, PhD, Gut, Robert Z., MD, PhD, Cooper, David L., MD, MBA
Published in Value in health (01.09.2012)
Published in Value in health (01.09.2012)
Get full text
Journal Article
Impact of Acute Bleeding on Daily Activities of Patients with Congenital Hemophilia with Inhibitors and Their Caregivers and Families: Observations from the Dosing Observational Study in Hemophilia (DOSE)
Recht, Michael, MD, PhD, Neufeld, Ellis J., MD, PhD, Sharma, Vivek R., MD, FACP, Solem, Caitlyn T., PhD, Pickard, A. Simon, PhD, Gut, Robert Z., MD, PhD, Cooper, David L., MD
Published in Value in health (01.09.2014)
Published in Value in health (01.09.2014)
Get full text
Journal Article
Assessment of acquired hemophilia patient demographics in the United States: the Hemostasis and Thrombosis Research Society Registry
Kessler, Craig M, Ma, Alice D, Al-Mondhiry, Hamid A B, Gut, Robert Z, Cooper, David L
Published in Blood coagulation & fibrinolysis (01.10.2016)
Published in Blood coagulation & fibrinolysis (01.10.2016)
Get more information
Journal Article
Use of recombinant activated factor VII for acute bleeding episodes in acquired hemophilia: final analysis from the Hemostasis and Thrombosis Research Society Registry acquired hemophilia study
Ma, Alice D, Kessler, Craig M, Al-Mondhiry, Hamid A B, Gut, Robert Z, Cooper, David L
Published in Blood coagulation & fibrinolysis (01.10.2016)
Published in Blood coagulation & fibrinolysis (01.10.2016)
Get more information
Journal Article
A novel supplemental approach to capturing post-marketing safety information on recombinant factor VIIa in acquired hemophilia: the Acquired Hemophilia Surveillance project
Lentz, Steven R, Tandra, Anand, Gut, Robert Z, Cooper, David L
Published in Journal of blood medicine (01.01.2014)
Published in Journal of blood medicine (01.01.2014)
Get full text
Journal Article
Capturing daily assessments and home treatment of congenital hemophilia with inhibitors: design, disposition, and implications of the Dosing Observational Study in Hemophilia (DOSE)
Young, Guy, Solem, Caitlyn T, Hoffman, Kate, Kabawat, Jenna, Pickard, A Simon, Gut, Robert Z, Cooper, David L
Published in Journal of blood medicine (01.01.2012)
Published in Journal of blood medicine (01.01.2012)
Get full text
Journal Article
Stable and durable factor IX levels in hemophilia B patients over 3 years post etranacogene dezaparvovec gene therapy
von Drygalski, Annette, Gomez, Esteban, Giermasz, Adam, Castaman, Giancarlo, Key, Nigel S, Lattimore, Susan S, Leebeek, Frank W G, Miesbach, Wolfgang A, Recht, Michael, Gut, Robert Z, Dolmetsch, Ricardo, Monahan, Paul E, Le Quellec, Sandra, Pipe, Steven W
Published in Blood advances (09.12.2022)
Get full text
Published in Blood advances (09.12.2022)
Journal Article
US Experience with Recombinant Factor VIIa (rFVIIa) for Surgery in Acquired Hemophilia (AH): Analysis From the Hemophilia and Thrombosis Research Society (HTRS) Registry
Al-Mondhiry, Hamid A B, Ma, Alice D., Kessler, Craig M., Fisher, Margaret, Gut, Robert Z., Cooper, David L.
Published in Blood (16.11.2012)
Published in Blood (16.11.2012)
Get full text
Journal Article
The Hemostasis and Thrombosis Research Society (HTRS) Registry Study of Acquired Hemophilia: Assessment of AH Patient Demographics in the US
Kessler, Craig M., Ma, Alice D., Al-Mondhiry, Hamid A B, Fisher, Margaret, Gut, Robert Z., Cooper, David L.
Published in Blood (16.11.2012)
Published in Blood (16.11.2012)
Get full text
Journal Article
Recombinant Factor VIIa (rFVIIa) Is Safe and Effective When Used to Treat Acute Bleeding Episodes and to Prevent Bleeding During Surgery in Patients with Acquired Hemophilia: Updated Assessment From the Hemostasis and Thrombosis Research Society (HTRS) Registry AH Database
Get full text
Journal Article
Safety of Recombinant Activated Factor VII (rFVIIa) in Patients with Congenital Hemophilia with Inhibitors: Overall Dose Exposure and Intervals Following >240 Mcg/Kg Doses Across Trial, Registry and Diary Studies
Shapiro, Amy D., Neufeld, Ellis J., Blanchette, Victor S., Chambost, Hervé, Salaj, Peter, Gut, Robert Z., Cooper, David L.
Published in Blood (18.11.2011)
Published in Blood (18.11.2011)
Get full text
Journal Article